nach oben

memo - Magazine of European Medical Oncology

Erschienen in:

01.12.2015 | short review

Thermoablation: a new treatment option to replace surgical intervention?

verfasst von: Dr. Herbert Schuster, MD, Dr. Helmut Kopf

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Local tumor ablation either by high or low temperatures is an ever increasing local therapeutic procedure in the interdisciplinary armamentarium of anticancer therapy. As cryoablation (local cancer tissue destruction by low temperature) is technically demanding, rather expansive and thus has gained low acceptance and low distribution in interventional oncologic radiology, this paper will focus on the state-of-the-art of local tumor cell destruction by high temperatures and electroporation: radiofrequency ablation (RFA), microwave ablation (MWA), and irreversible electroporation (IRE).

Vorheriger Artikel Malignant pleural effusion: pathogenesis, diagnosis, and management

Nächster Artikel Giant Merkel cell carcinoma of the face, immediate results after radiation therapy: a case report and review of the literature

Crocetti L, de Baere T, Lencioni R. Quality improvement guidelines for radiofrequency ablation of liver tumors. Cardiovasc Intervent Radiol. 2010;33:11–7. doi:10.1007/s00270-009-9736-y.(CIRSE Guidelines)PubMedPubMedCentralCrossRef

Bruix J, Sherman M, Llovet JM, et al.; EASL panel of experts on HCC. Clinical management of study of the liver. J Hepatol. 2001;35:421–30.

Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208–36.PubMedCrossRef

Lencioni R, Allgaier HP, Cioni D, et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radiofrequency thermal ablation versus percutaneous ethanol injection. Radiology. 2003;228(1):235–40PubMedCrossRef

Llovet JM, Vilana R, Bru C, et al.; Barcelona Clinic Liver Cancer (BCLC) Group. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology. 2001;33:1124–9.

Ruers T, et al. Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004). Ann Oncol. 2012;23(10):2619–26.PubMedPubMedCentralCrossRef

Ruers T, et al. Radiofrequency ablation (RFA) combined with chemotherapy for unresectable colorectal liver metastases (CRC LM): long-term survival results of a randomized phase II study of the EORTC-NCRI CCSG- ALM Intergroup 40004 (CLOCC). J Clin Oncol. 2015; 33. (suppl; abstr 3501; oral presentation)

Dietrich CF, Cui XW, Chiorean L, Appelbaum L, Leen E, Ignee A. Local ablative procedures of the liver. Z Gastroenterol. 2015;53(06):579–90. doi:10.1055/s-0034-1399446.PubMedCrossRef

Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg. 2006;243(3):321–8.PubMedPubMedCentralCrossRef

10.

Lu MD, Kuang M, Liang LJ, Xie XY, Peng BG, et al. Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial. Zhonghua Yi Xue Za Zhi. 2006;86(12):801–5.PubMed

11.

Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, et al. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg. 2005;242(2):158–71.PubMedPubMedCentralCrossRef

12.

Silen W. Hepatic resection for metastases from colorectal carcinoma is of dubious value. Arch Surg. 1989;124(9):1021–2.PubMedCrossRef

13.

Livraghi T, Solbiati L, Meloni F, Ierace T, Goldberg SN, et al. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection. The “Test-of-Time” approach. Cancer. 2003;97(12):3027–35.PubMedCrossRef

14.

Scorsetti M, Clerici E, Comito T. Stereotactic body radiation therapy for liver metastases J Gastrointest Oncol. 2014;5(3):190–7. doi:10.3978/j.issn.2078–6891.2014.039.PubMedPubMedCentral

15.

Abi-Jaoudeh N, Kruecker J, Kadoury S, et al. Multimodality image fusion-guided procedures: technique, accuracy and applications. Cardiovasc Intervent Radiol. 2012;35:986–98.PubMedPubMedCentralCrossRef

16.

Wood BJ, Kruecker J, Abi-Jaoudeh N, et al. Navigation systems for ablation. J Vasc Interv Radiol. 2010;21:257–63.CrossRef

17.

Wallach D, Toporek G, Weber S, Bale R, Widmann G. Comparison of freehand-navigated and aiming device-navigated targeting of liver lesions. Int J Med Robot. 2014;10(1):35–43.PubMedCrossRef

18.

Peng ZW, Zhang YJ, Chen MS, et al. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. J Clin Oncol. 2013;31:426–32.PubMedCrossRef

19.

Strickland AD, Clegg PJ, Cronin NJ, et al. Experimental study of large-volume microwave ablation in the liver. Br J Surg. 2002;89(8):1003–7.PubMedCrossRef

20.

Yang D, Converse MC, Mahvi DM, Webster JG. Measurement and analysis of tissue temperature during microwave liver ablation. IEEE Trans Biomed Eng. 2007;54(1):150–5.PubMedCrossRef

21.

Wang Y, Sun Y, Feng L, Gao Y, Ni X, Liang P. Internally cooled antenna for microwave ablation: results in ex vivo and in vivo porcine livers. Eur J Radiol. 2008;67(2):357–61.PubMedCrossRef

22.

Van Sonnenberg E, McMullen W, Solbiati L. Tumor ablation. Principles and practice. New York: Springer; 2005.CrossRef

23.

Davalos R, Mir LM, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng. 2005;33(2):223–31.PubMedCrossRef

24.

Maor E, Ivorra A, Leor J, Rubinsky B. The effect of irreversible electroporation on blood vessels. Technol Cancer Res Treat. 2007;6(307):307–12.PubMedCrossRef

25.

Narayanan G, Bhatia S, Echenique A, Suthar R, Barbery K, Yrizarry J. Vessel patency post irreversible electroporation. Cardiovasc Intervent Radiol. 2014;37(6):1523–9.PubMedCrossRef

26.

Weng M, Zhang Y, Zhou D, Yang Y, Tang Z, Zhao M, Quan Z, Gong W. Radiofrequency ablation versus resection for colorectal cancer liver metastases: a meta-analysis. PLoS One. 2012;7(9):e45493. doi:10.1371/journal.pone.0045493.PubMedPubMedCentralCrossRef

27.

Lencioni R, Crocetti L, Cioni D et al (2004) Percutaneous radiofrequency ablation of hepatic colorectal metastases. Technique, indications, results, and new promises. Invest Radiol 39:689–697

28.

Gillams AR, Lees WR (2004) Radio-frequency ablation of colorectal liver metastases in 167 patients. Eur Radiol 14:2261–2267

29.

Machi J, Oishi AJ, Sumida K et al (2006) Long-term outcome of radiofrequency ablation for unresectable liver metastases from colorectal cancer: evaluation of prognostic factors and effectiveness in first- and second-line management. Cancer J 12:318–326

30.

Sorensen SM, Mortensen FV, Nielsen DT (2007) Radiofrequency ablation of colorectal liver metastases: long-term survival. Acta Radiol 48:253–258

31.

Veltri A, Sacchetto P, Tosetti I, Pagano E, Fava C, Gandini G (2008) Radiofrequency ablation of colorectal liver metastases: small size favorably predicts technique effectiveness and survival. Cardiovasc Intervent Radiol 31:948–956

Titel: Thermoablation: a new treatment option to replace surgical intervention?
verfasst von: Dr. Herbert Schuster, MD
Dr. Helmut Kopf
Publikationsdatum: 01.12.2015
Verlag: Springer Vienna
Erschienen in: memo - Magazine of European Medical Oncology / Ausgabe 4/2015
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-015-0232-6

Springer Medizin Österreich

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2015

ASCO update 2015: lung cancer

ASCO 2015: Highlights in breast cancer

Obituary for Dr. Ferdinand Ploner

ASCO 2015: highlights in colorectal cancer

Clinical relevance of circulating tumor cells in cancer patients

Giant Merkel cell carcinoma of the face, immediate results after radiation therapy: a case report and review of the literature